G J Dore

Summary

Affiliation: University of New South Wales
Country: Australia

Publications

  1. pmc Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
    Anchalee Avihingsanon
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia
    AIDS Res Ther 9:6. 2012
  2. pmc Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study
    Heather F Gidding
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    BMC Public Health 11:52. 2011
  3. pmc Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort
    Suzy Teutsch
    School of Medical Sciences, The University of New South Wales, Sydney, New South Wales, Australia
    BMC Public Health 10:633. 2010
  4. ncbi request reprint Is severe liver disease a common outcome for people with chronic hepatitis C?
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 376 Victoria Street Level 2, Darlinghurst, Sydney, New South Wales 2010, Australia
    J Gastroenterol Hepatol 17:423-30. 2002
  5. pmc Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    AIDS 24:857-65. 2010
  6. ncbi request reprint HAART's first decade: success brings further challenges
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney 2010, New South Wales, Australia
    Lancet 368:427-8. 2006
  7. ncbi request reprint Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    Semin Liver Dis 25:18-32. 2005
  8. ncbi request reprint Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings
    Gregory J Dore
    Nationa Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    Antivir Ther 8:365-72. 2003
  9. pmc Effective treatment of injecting drug users with recently acquired hepatitis C virus infection
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    Gastroenterology 138:123-35.e1-2. 2010
  10. ncbi request reprint Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
    AIDS 21:1555-9. 2007

Detail Information

Publications103 found, 100 shown here

  1. pmc Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
    Anchalee Avihingsanon
    The Kirby Institute for Infection and Immunity in Society, University of New South Wales, Sydney, Australia
    AIDS Res Ther 9:6. 2012
    ..abstract:..
  2. pmc Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study
    Heather F Gidding
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    BMC Public Health 11:52. 2011
    ..In this study, we compared hospitalization rates for all causes and viral liver disease in people notified with HBV or HCV in New South Wales (NSW), Australia...
  3. pmc Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort
    Suzy Teutsch
    School of Medical Sciences, The University of New South Wales, Sydney, New South Wales, Australia
    BMC Public Health 10:633. 2010
    ..Previous studies of HCV incidence have been based on small case numbers and have not distinguished risk events in prison from those in the community...
  4. ncbi request reprint Is severe liver disease a common outcome for people with chronic hepatitis C?
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 376 Victoria Street Level 2, Darlinghurst, Sydney, New South Wales 2010, Australia
    J Gastroenterol Hepatol 17:423-30. 2002
    ..Those groups include people with a heavy alcohol intake, those who have coinfection with HIV or HBV, and those who have already progressed to moderate to severe hepatic fibrosis...
  5. pmc Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    AIDS 24:857-65. 2010
    ..The impact of antiretroviral therapy (ART) interruption in HIV-hepatitis B virus (HBV)-coinfected patients was examined in the Strategic Management of AntiRetroviral Therapy (SMART) study...
  6. ncbi request reprint HAART's first decade: success brings further challenges
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney 2010, New South Wales, Australia
    Lancet 368:427-8. 2006
  7. ncbi request reprint Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    Semin Liver Dis 25:18-32. 2005
    ....
  8. ncbi request reprint Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings
    Gregory J Dore
    Nationa Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    Antivir Ther 8:365-72. 2003
    ..Further models are required to determine individual prognosis and should be based on an assessment of cofactors for liver disease progression...
  9. pmc Effective treatment of injecting drug users with recently acquired hepatitis C virus infection
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    Gastroenterology 138:123-35.e1-2. 2010
    ..We evaluated the efficacy of treatment of recent HCV infection in IDUs with acute and early chronic HCV...
  10. ncbi request reprint Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
    AIDS 21:1555-9. 2007
    ..To identify baseline characteristics predictive of a sustained virological response (SVR) in patients with HIV-hepatitis C virus (HCV) co-infection treated with interferon-based therapy...
  11. ncbi request reprint The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses
    G J Dore
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Australia
    Curr Opin Infect Dis 14:749-55. 2001
    ..A possible role may also exist for combined antiviral and immune-based therapies...
  12. ncbi request reprint Trends in infectious disease mortality in Australia, 1979-1994
    G J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney
    Med J Aust 168:601-4. 1998
    ..To examine trends in infectious disease mortality in Australia over the period 1979-1994...
  13. ncbi request reprint Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
    G J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, Australia
    AIDS 13:1249-53. 1999
    ....
  14. ncbi request reprint Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee
    G J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    J Infect Dis 180:607-13. 1999
    ..001). A trend to lower alanine transferase level, and delayed progression of HIV-1 disease (relative hazard, 0.26; 95% confidence interval, 0.08-0.80) were also seen in the lamivudine arms, compared with the placebo group...
  15. ncbi request reprint Infectious diseases in the 21st century. Are we entering the hot zone?
    G J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney
    Aust Fam Physician 29:627-30. 2000
    ..The emergence and re-emergence of several infectious diseases in the latter part of the 20th century has created considerable concern, but what real impact will these and other infectious diseases have in the 21st century?..
  16. ncbi request reprint Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    J Infect Dis 189:1185-92. 2004
    ..Lamivudine has potent activity against both HIV-1 and HBV; however, lamivudine-resistance mutations in HBV frequently develop...
  17. ncbi request reprint Spectrum of AIDS-defining illnesses in Australia, 1992 to 1998: influence of country/region of birth
    G J Dore
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Darlinghurst, Australia
    J Acquir Immune Defic Syndr 26:283-90. 2001
    ..To examine the influence of country/region of birth on spectrum of AIDS-defining illness...
  18. ncbi request reprint Epidemiology of hepatitis C virus infection in Australia
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Level 2, 376 Victoria Street, Darlinghurst, Sydney 2010, NSW, Australia
    J Clin Virol 26:171-84. 2003
    ....
  19. ncbi request reprint Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    J Acquir Immune Defic Syndr 29:388-95. 2002
    ..To determine the effect of highly active antiretroviral therapy (HAART) on incidence of initial AIDS-defining illnesses (ADIs) and survival after individual ADIs...
  20. pmc Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study
    J Grebely
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
    Drug Alcohol Depend 107:244-9. 2010
    ..Decisions about whether to initiate treatment for recently acquired HCV were mainly driven by clinical factors, rather than factors related to sociodemographics or injecting behaviors...
  21. ncbi request reprint High incidence of hepatitis C virus reinfection within a cohort of injecting drug users
    J M Micallef
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Australia
    J Viral Hepat 14:413-8. 2007
    ..Following adjustment for HCV risk behaviour variables the incidence rate ratio of HCV reinfection to initial infection was 1.11 (P = 0.8). Several cases of HCV reinfection appear to have developed persistent infection...
  22. pmc Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C
    G V Matthews
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    Clin Infect Dis 48:650-8. 2009
    ..Enrollment is open to both human immunodeficiency virus (HIV)-infected and -uninfected individuals. The aim of this article was to evaluate characteristics and virological outcomes among HIV-infected individuals enrolled in ATAHC...
  23. doi request reprint Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening
    Monica C Robotin
    The Cancer Council NSW, Research Strategy and Scientific Development Unit, 153 Dowling St, Woolloomooloo, NSW 2011, Sydney, Australia
    J Hepatol 50:990-8. 2009
    ..We therefore, modelled the consequences of different management strategies for chronic hepatitis B (CHB) in Asian-born adults aged > or = 35 years...
  24. doi request reprint Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents
    J Grebely
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Australia
    J Viral Hepat 18:32-41. 2011
    ..HCV-infected inner city residents >50 years of age were at significant risk of liver-related mortality. Continued surveillance of this population infected with HCV in the 1970s and 1980s is important...
  25. ncbi request reprint Improved cognitive function as a consequence of hepatitis C virus treatment
    H H Thein
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Australia
    HIV Med 8:520-8. 2007
    ..The aim of the study was to investigate the impact of treatment-related clearance of hepatitis C virus (HCV) on cognitive function...
  26. doi request reprint Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007
    H H Thein
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Australia
    J Viral Hepat 18:e232-41. 2011
    ..Despite declines in the age-adjusted incidence rates of HCC over time, the absolute number of cases increased likely due to the ageing cohort and an increasing prevalence of both hepatitis B and C in Australia...
  27. ncbi request reprint Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality
    M G Law
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney
    Med J Aust 173:403-5. 2000
    ....
  28. pmc Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C
    G V Matthews
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    Clin Infect Dis 52:803-11. 2011
    ..The extent to which these separate epidemics overlap is unknown...
  29. pmc Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users
    J Amin
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    Epidemiol Infect 135:144-50. 2007
    ..Standardized definitions and methodologies are required to enable valid comparisons of rates of clearance across newly acquired HCV infection natural history studies...
  30. ncbi request reprint HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy
    D Lincoln
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    HIV Med 4:241-9. 2003
    ..To assess the prevalence and risk factors for HBV and HCV coinfection in the Australia HIV Observational Database (AHOD), and examine outcomes of HIV disease following initiation of highly active antiretroviral therapy (HAART)...
  31. doi request reprint Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C
    H F Gidding
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    Epidemiol Infect 139:1151-8. 2011
    ..The results are likely to be representative of patterns in hospital-related morbidity for the entire HCV-infected population in Australia and the ARs generalizable to other developed countries...
  32. doi request reprint IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy
    Vijayaprakash Suppiah
    Storr Liver Unit, University of Sydney, Sydney, Australia
    Nat Genet 41:1100-4. 2009
    ..These data suggest that host genetics may be useful for the prediction of drug response, and they also support the investigation of the role of IL28B in the treatment of HCV and in other diseases treated with IFN-alpha...
  33. ncbi request reprint Epidemiology of hepatitis C virus infection in Australia
    Gregory J Dore
    Viral Hepatitis Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales
    Aust Fam Physician 32:796-8. 2003
  34. ncbi request reprint Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001
    W Phillip Law
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    AIDS 17:2191-9. 2003
    ..To examine rates and predictors of severe hepatotoxicity with combination antiretroviral therapy in a developing country setting: the eight HIV-NAT randomized controlled trials in Thailand...
  35. doi request reprint Experience of hepatitis C testing among injecting drug users in Sydney, Australia
    C A Day
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    AIDS Care 20:116-23. 2008
    ..Specialised services for drug users such as methadone clinics and primary healthcare are suitable locations to provide access to testing...
  36. ncbi request reprint Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    AIDS 17:1539-45. 2003
    ..To determine the effect of introduction of highly active antiretroviral therapy (HAART) on survival following AIDS dementia complex (ADC)...
  37. ncbi request reprint Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort
    W Phillip Law
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Darlinghurst, Sydney, Australia
    AIDS 18:1169-77. 2004
    ..To examine the impact of viral hepatitis co-infection on HIV disease outcomes following commencement of combination antiretroviral therapy in a developing country setting...
  38. doi request reprint Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance
    Kerry Lee Milner
    Garvan Institute for Medical Research, University of New South Wales 2010, Sydney, Australia
    Gastroenterology 138:932-41.e1-3. 2010
    ..Chronic hepatitis C (CHC) is associated with insulin resistance (IR), liver steatosis (genotype 3), and increased diabetes risk. The site and mechanisms of IR are unclear...
  39. ncbi request reprint Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy
    Richard Hallinan
    The Byrne Surgery, Redfern, New South Wales, Australia
    J Gastroenterol Hepatol 20:1082-6. 2005
    ..To determine hepatitis C virus (HCV) prevalence among injecting drug users (IDUs) receiving opioid replacement therapy in a referred office setting, and assess potential needs for hepatitis C treatment and care...
  40. ncbi request reprint Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database
    Jialun Zhou
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    J Gastroenterol Hepatol 22:1510-8. 2007
    ....
  41. ncbi request reprint Highly endemic hepatitis B infection in rural Vietnam
    Van Thi Thuy Nguyen
    School of Public Health and Community Medicine, The University of New South Wales, Sydney, Australia
    J Gastroenterol Hepatol 22:2093-100. 2007
    ..The aim of this study was to determine HBV and HDV prevalence, and identify risk factors for HBV infection...
  42. doi request reprint CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection
    V Suppiah
    Storr Liver Unit, Westmead Millennium Institute, University of Sydney, Sydney, NSW, Australia
    Genes Immun 14:286-90. 2013
    ..Although CCR5-Δ32 may affect viral clearance within closely controlled geographical and genetic environments, we found no effect in larger cohorts treated with dual therapy. ..
  43. ncbi request reprint Estimating progression to cirrhosis in chronic hepatitis C virus infection
    A J Freeman
    Viral Hepatitis Research, Gastrointestinal and Liver Unit, The Prince of Wales Hospital, Sydney, Australia
    Hepatology 34:809-16. 2001
    ..These suggest that for persons who acquire HCV infection in young adulthood, less than 10% are estimated to develop cirrhosis within 20 years...
  44. ncbi request reprint HIV and hepatitis C coinfection within the CAESAR study
    J Amin
    National Centre in HIV Epidemiology and Clinical Research NCHECR, The University of New South Wales, Level 2, 376 Victoria Street, Darlinghurst, Sydney 2010, Australia
    HIV Med 5:174-9. 2004
    ..The low prevalence of HIV/HCV coinfection among homosexual men without a history of IDU suggests low efficiency of sexual HCV transmission...
  45. ncbi request reprint Predicting progression to cirrhosis in chronic hepatitis C virus infection
    A J Freeman
    National Centre in HIV Epidemiology and Clinical Research, and The University of New South Wales, Sydney, Australia
    J Viral Hepat 10:285-93. 2003
    ..A Weibull distribution was used to model disease progression at a population level. The influence of cofactors on individual prognosis was examined and an algorithm to predict the risk of subsequently developing cirrhosis is presented...
  46. ncbi request reprint Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries
    Van Thi Thuy Nguyen
    School of Public Health and Community Medicine, The University of New South Wales, Sydney, New South Wales, Australia
    J Gastroenterol Hepatol 23:922-9. 2008
    ..This study estimates immigration-related chronic HBV cases, chronic HBV prevalence, and HBV-related hepatocellular carcinoma (HCC) from 1960 to 2005 and projects HBV-related HCC to 2025 in Australia among people born in the APR...
  47. ncbi request reprint Clearance of hepatitis C virus after newly acquired infection in injection drug users
    Marianne Jauncey
    New South Wales Public Health Officer Training Program, New South Wales Department of Health, Kirketon Road Centre, South Eastern Sydney Area Health Service, Sydney, New South Wales, Australia
    J Infect Dis 190:1270-4. 2004
    ..Viral clearance occurred in 24 (42%) cases, with Kaplan-Meier estimated probabilities of 23%, 38%, and 40% at 6, 12, and 24 months, respectively...
  48. doi request reprint Frequent multiple hepatitis C virus infections among injection drug users in a prison setting
    Son T Pham
    School of Biotechnology and Biomolecular Sciences, Faculty of Science, Sydney, Australia
    Hepatology 52:1564-72. 2010
    ..Spontaneous clearance of viruses from one subtype and persistence of the other subtype after mixed infection was observed in eight subjects. In these subjects, the virus with higher HCV RNA levels superseded the other...
  49. ncbi request reprint Treatment for hepatitis C virus infection among current injection drug users in Australia
    Gail Matthews
    Viral Hepatitis Program, National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Darlinghurst, Australia
    Clin Infect Dis 40:S325-9. 2005
    ..Further studies are under way to examine outcomes of treatment for HCV among clients undergoing treatment for drug dependency who have chronic HCV infection and among current IDUs with acute and newly acquired HCV infection...
  50. ncbi request reprint Lower life expectancy among people with an HCV notification: a population-based linkage study
    M Alavi
    The Kirby Institute, UNSW Australia, Sydney, NSW, Australia
    J Viral Hepat 21:e10-8. 2014
    ..Following removal of drug-related mortality, life expectancy in this population remained considerably lower, compared with the general population...
  51. doi request reprint Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden
    V T T Nguyen
    School of Public Health and Community Medicine, The University of New South Wales, Sydney, Australia
    J Viral Hepat 16:453-63. 2009
    ..Broad public health strategies should include routine testing to identify chronic HBV infection, improved health infrastructures including human resource to provide diagnosis and treatment assessment...
  52. doi request reprint Modelling and calibration of the hepatitis C epidemic in Australia
    K Razali
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Australia
    Stat Methods Med Res 18:253-70. 2009
    ..The reasonably good agreement between most of the modelled estimates with observed linkage data provides some support for the assumptions used in the models...
  53. ncbi request reprint Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies
    J M Micallef
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Darlinghurst, Sydney, NSW, Australia
    J Viral Hepat 13:34-41. 2006
    ..29). Factors associated with viral clearance were female gender and acute clinical hepatitis C study population. Further studies are required to more clearly define predictors of clearance and guide therapeutic intervention strategies...
  54. doi request reprint Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia
    Van T T Nguyen
    School of Public Health and Community Medicine, The University of New South Wales, Sydney, New South Wales, Australia
    J Gastroenterol Hepatol 24:436-42. 2009
    ..An increasing proportion of HCC cases is related to chronic viral hepatitis including hepatitis B virus (HBV) infection. However, there is very limited data on HBV-related HCC survival...
  55. ncbi request reprint HIV and hepatitis C coinfection
    Gail V Matthews
    Viral Hepatitis Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales, Australia
    J Gastroenterol Hepatol 23:1000-8. 2008
    ..New therapies, including HCV protease and polymerase inhibitors, are in development and may widen therapeutic options for HIV-HCV-coinfected individuals into the future...
  56. pmc Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals
    Gail V Matthews
    National Centre in HIV Epidemiology and Clinical Research, UNSW, Sydney, Australia
    AIDS 23:1707-15. 2009
    ..To determine if highly active antiretroviral therapy (HAART) with combination anti-hepatitis B virus (HBV) therapy compared to HAART with HBV monotherapy leads to greater HBV DNA suppression in an HIV/HBV coinfected cohort...
  57. doi request reprint A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand
    Gail V Matthews
    Viral Hepatitis Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, Sydney, NSW, Australia
    Hepatology 48:1062-9. 2008
    ..Hepatitis B e antigen (HBeAg) loss was observed in 33% of HBeAg-positive subjects, and 8% experienced hepatitis B surface antigen loss. Hepatic flare was observed in 25% of subjects...
  58. pmc Prevalence and risk factors for hepatitis C infection in rural north Vietnam
    Van Thi Thuy Nguyen
    School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
    Hepatol Int 1:387-93. 2007
    ..A community-based study was used to determine the prevalence of HCV infection in a rural population of north Vietnam and explore risk factors associated with HCV acquisition...
  59. ncbi request reprint The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006
    Heather F Gidding
    National Centre in HIV Epidemiology and Clinical Research, Darlinghurst, NSW 2010, Australia
    J Gastroenterol Hepatol 24:1648-54. 2009
    ..The aim of this study was to examine trends in the epidemiology and treatment of HCV in Australia...
  60. doi request reprint An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025
    Van Thi Thuy Nguyen
    School of Public Health and Community Medicine, The University of New South Wales, Sydney, Australia
    Liver Int 28:525-31. 2008
    ..This study aimed to estimate and project chronic HBV prevalence and HBV-related liver cirrhosis (LC) and hepatocellular carcinoma (HCC) for the period 1990-2025...
  61. ncbi request reprint Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
    Gail V Matthews
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    AIDS 20:863-70. 2006
    ..Little is known about the prevalence and pattern of hepatitis B virus (HBV) mutations in HIV/HBV co-infected individuals on long-term lamivudine (3TC) therapy...
  62. ncbi request reprint Late HIV presentation among AIDS cases in Australia, 1992-2001
    Ann M McDonald
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, for the National HIV Surveillance Committee, Darlinghurst
    Aust N Z J Public Health 27:608-13. 2003
    ..To describe time trends and demographic, exposure and clinical factors associated with late HIV presentation among notified AIDS cases diagnosed in Australia in 1992-2001...
  63. ncbi request reprint Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study
    Janaki Amin
    National Centre in HIV Epidemiology and Clinical Research, Sydney, Australia
    J Hepatol 45:197-203. 2006
    ..The aim was to quantify the risk of cancers among persons diagnosed with HBV/HCV infections...
  64. ncbi request reprint Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001
    Matthew G Law
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
    Int J Epidemiol 32:717-24. 2003
    ....
  65. ncbi request reprint Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study
    Janaki Amin
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, NSW 2010, Australia
    Lancet 368:938-45. 2006
    ..Hepatitis B and hepatitis C virus infections are common causes of death related to liver disease. In this large study, we aimed to investigate all cause mortality of the viruses in a community-based setting...
  66. ncbi request reprint Referral for chronic hepatitis C treatment from a drug dependency treatment setting
    Richard Hallinan
    The Byrne Surgery, 75 Redfern Street, Redfern, NSW, Australia
    Drug Alcohol Depend 88:49-53. 2007
    ..Preliminary HCV treatment outcomes are encouraging and highlight the potential for reducing liver disease burden in this patient population...
  67. pmc Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection
    Jason Grebely
    National Centre in HIV Epidemiology and Clinical Research NCHECR, University of New South Wales UNSW, Sydney, Australia
    Hepatology 52:1216-24. 2010
    ..Early therapeutic intervention could be recommended for individuals with unfavorable IL28B genotypes...
  68. ncbi request reprint Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, Australia
    Heather F Gidding
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    J Hepatol 53:43-9. 2010
    ..We examined condition specific (principal diagnosis) and overall hospitalization rates for the cohort of individuals notified with hepatitis C in New South Wales (NSW), Australia...
  69. doi request reprint Reinfection with hepatitis C virus following sustained virological response in injection drug users
    Jason Grebely
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, New South Wales, Australia
    J Gastroenterol Hepatol 25:1281-4. 2010
    ..However, there are little data in this regard. We evaluated HCV re-infection following sustained virologic response (SVR) among HCV-infected IDUs having received HCV treatment in a multidisciplinary program...
  70. ncbi request reprint Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir
    Gail V Matthews
    HIV Immunology Infectious Diseases Unit, St Vincent s Hospital, Sydney, Australia
    Antivir Ther 12:119-22. 2007
    ..The safety and efficacy of tenofovir in HIV/HBV cirrhosis has not been previously described...
  71. ncbi request reprint Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia
    Anna Doab
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    Clin Infect Dis 40:S313-20. 2005
    ..Study participants at the methadone clinic had higher levels of consideration of treatment. These findings support the development of specific education programs regarding treatment for HCV infection for current IDUs...
  72. ncbi request reprint Harm reduction, hepatitis C and opioid pharmacotherapy: an opportunity for integrated hepatitis C virus-specific harm reduction
    Richard Hallinan
    The Byrne Surgery Redfern, NSW, Australia
    Drug Alcohol Rev 26:437-43. 2007
    ..This paper provides some practical suggestions as to how this can be done...
  73. pmc The effect of hepatitis C virus infection on health-related quality of life in prisoners
    Hla Hla Thein
    National Centre in HIV Epidemiology and Clincal Research, The University of New South Wales, Sydney, NSW, Australia
    J Urban Health 83:275-88. 2006
    ..Non-HCV factors may override HCV-specific HRQOL impairment in this population. Targeted management strategies are required to improve HRQOL of prisoners...
  74. ncbi request reprint Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre
    Virginia Macdonald
    The Kirketon Road Centre, South Eastern Sydney and Illawarra Area Health Service, Sydney, NSW 2011, Australia
    Sex Health 4:27-30. 2007
    ..This study aims to identify rates and predictors of completion of a HBV vaccination schedule in 'high-risk' attendees of a primary health care centre in Sydney...
  75. ncbi request reprint Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection
    Mark Danta
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW
    Med J Aust 177:240-5. 2002
    ..To determine factors associated with hepatic fibrosis development in people with chronic hepatitis C virus (HCV) infection...
  76. ncbi request reprint Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study
    C Treloar
    National Centre in HIV Social Research, The University of New South Wales, Sydney, NSW, Australia
    J Viral Hepat 21:560-7. 2014
    ..Further, the importance of a changing discourse of treatment is apparent from these data and could be enhanced by peer communication that provides information about successful treatment experiences. ..
  77. doi request reprint Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia
    J Grebely
    Viral Hepatitis Clinical Research Program, National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW, Australia
    J Viral Hepat 18:e104-16. 2011
    ..22, P < 0.001). These data identify modifiable patient-, provider- and systems-level barriers associated with HCV assessment and treatment in the community that could be addressed by targeted interventions...
  78. ncbi request reprint Hepatitis C in Australia: impact of a mass media campaign
    Ben J Smith
    School of Public Health, University of Sydney, Sydney, NSW, Australia
    Am J Prev Med 31:492-8. 2006
    ..Hepatitis C affects over 200,000 Australians. This study evaluated the impact of a public education campaign about this disease in New South Wales (NSW), Australia...
  79. ncbi request reprint Surveillance for newly acquired hepatitis C in Australia
    Monica C Robotin
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales, Australia
    J Gastroenterol Hepatol 19:283-8. 2004
    ..The purpose of the present paper was to determine recent patterns of hepatitis C virus (HCV) transmission in Australia through a national system of enhanced surveillance of newly acquired hepatitis C...
  80. ncbi request reprint Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole
    G J Dore
    Department of Microbiology, St Vincent s Hospital, Sydney, Australia
    Clin Infect Dis 21:70-6. 1995
    ..There was a parallel parasitological response, with clearance of S. intestinalis infection from almost all sites...
  81. doi request reprint Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study
    Anna Doab
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst NSW 2010, Australia
    Contemp Clin Trials 30:431-5. 2009
    ....
  82. ncbi request reprint Estimation of utilities for chronic hepatitis C from SF-36 scores
    Hla Hla Thein
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Australia
    Am J Gastroenterol 100:643-51. 2005
    ..The aim of this study was to estimate utilities for chronic hepatitis C health states from published studies reporting Short Form-36 (SF-36) quality-of-life scores...
  83. ncbi request reprint Infant feeding practices and attitudes among women with HIV infection in northern Thailand
    S Talawat
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2, 376 Victoria Street, Darlinghurst, NSW 2010, Australia
    AIDS Care 14:625-31. 2002
    ..However, once women with HIV infection are informed of the risk of HIV transmission through breastfeeding, they are able to make their own decision to follow the Thai Ministry of Public Health's recommendation to formula feed...
  84. ncbi request reprint Cost-effectiveness of treatment for chronic hepatitis C infection
    Gregory J Dore
    JAMA 290:1993; author reply 1994. 2003
  85. ncbi request reprint Review of antenatal testing policies and practice for HIV and hepatitis C infection
    Jenean D Spencer
    Surveillance and Epidemiology Section, Population Health Division, Commonwealth Department of Health and Ageing, Australian Capital Territory
    Aust N Z J Public Health 27:614-9. 2003
    ..To investigate antenatal HIV and HCV testing policy and practice in Australia...
  86. ncbi request reprint Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok
    Narin Hiransuthikul
    Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    Southeast Asian J Trop Med Public Health 34:804-9. 2003
    ..Population-based tuberculin screening without accompanying HIV testing cannot be used to estimate the prevalence of actual latent TB in a population where HIV infection is widespread, such as in Thailand...
  87. ncbi request reprint Editorial comment: triple infection with HIV and hepatitis B and C viruses--lesson in combination therapy
    Gregory J Dore
    AIDS Read 14:392. 2004
  88. ncbi request reprint HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting
    Chris Duncombe
    HIV Netherlands Australia Thailand Research Collaboration, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    AIDS 19:169-78. 2005
    ..DESIGN, SETTING, PARTICIPANTS AND INTERVENTION: A cohort of 417 patients enrolled in a series of randomized ART trials, between 1996 and December 2002...
  89. ncbi request reprint Hepatitis C virus incidence among injecting drug users on opioid replacement therapy
    Richard Hallinan
    The Byrne Surgery, New South Wales
    Aust N Z J Public Health 28:576-8. 2004
    ..To determine hepatitis C virus (HCV) incidence among injecting drug users (IDUs) receiving opioid replacement therapy (ORT)...
  90. pmc Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance
    Scott Preiss
    Victorian Infectious Diseases Reference Laboratories, Research and Molecular Development, North Melbourne, Victoria, Australia
    Hepatology 48:741-9. 2008
    ..0001), indicating that antiviral drug resistance alters the balance between defective and genomic length DNA in circulation. Experiments in vitro using HBV encoding LMV-R mutations confirmed these results...
  91. doi request reprint Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression
    Hla Hla Thein
    University Health Network, Division of Clinical Decision Making and Health Care Research, Toronto, Ontario, Canada
    Hepatology 48:418-31. 2008
    ..Duration of infection was the most consistent factor significantly associated with progression of fibrosis...
  92. doi request reprint Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis C
    Stuart K Roberts
    The Alfred Hospital, Melbourne, Australia
    Hepatology 48:398-406. 2008
    ..Conclusion: These data support further studies of R1626 in combination with peginterferon alfa-2a and ribavirin for the treatment of patients with chronic HCV infection...
  93. ncbi request reprint Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al
    Gail V Matthews
    AIDS 21:2112-3. 2007
  94. ncbi request reprint Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: insights from the ATAHC study
    Oanh K Nguyen
    Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Vic, Australia
    Int J Drug Policy 18:447-51. 2007
    ....
  95. ncbi request reprint Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals
    Peter A Revill
    Victorian Infectious Diseases Reference Laboratory, 10 Wreckyn Street, North Melbourne, Victoria 3051, Australia
    AIDS 21:1701-10. 2007
    ..To test this hypothesis, we have analysed genome-length sequences of HBV DNA from patients both prior to and during antiviral therapy...
  96. ncbi request reprint Low incidence of HCV reinfection: exposure, testing frequency, or protective immunity?
    Gregory J Dore
    Hepatology 45:1330; author reply 1331. 2007
  97. ncbi request reprint Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'
    Gail V Matthews
    AIDS 21:777-8. 2007
  98. ncbi request reprint Enhancing hepatitis C treatment uptake and outcomes for injection drug users
    Gregory J Dore
    Hepatology 45:3-5. 2007
  99. ncbi request reprint Long-term outcome of vertically acquired and post-transfusion hepatitis C infection in children
    Sanguansak Rerksuppaphol
    Department of Gastroenterology and Clinical Nutrition, Royal Children s Hospital, Melbourne, Victoria, Australia
    J Gastroenterol Hepatol 19:1357-62. 2004
    ..Fifteen children had acquired HCV by blood transfusion (BT) prior to 6 months of age and 16 had vertically acquired (VT) HCV...
  100. ncbi request reprint Estimates of chronic hepatitis B virus infection in Australia, 2000
    Belinda G O'Sullivan
    New South Wales Public Health Officer Training Program, Department of Health, New South Wales
    Aust N Z J Public Health 28:212-6. 2004
    ..To estimate the prevalence of chronic hepatitis B virus (HBV) infection in Australia and attributable proportions associated with specific demographic groups at higher risk of infection...
  101. ncbi request reprint Blood-borne viruses and their survival in the environment: is public concern about community needlestick exposures justified?
    Sandra C Thompson
    Sexual Health and Blood borne Virus Program, Communicable Diseases Control Branch, Department of Health, Perth, Western Australia
    Aust N Z J Public Health 27:602-7. 2003
    ..We have undertaken a review of studies of blood-borne virus survival as the basis for advice and management of community needlestick injuries...